Showing results (101-110 of 128) with videos related to
Sort By:
Pageof 13
Respiratory Medicine|October 14, 2022
Outcomes of prednisone-tapering regimens for cardiac sarcoidosis: A retrospective analysis demonstrating a benefit of infliximabMarc A Judson, Evan Adelstein, Kenneth M Fish, et al.Lung|January 22, 2025
A Snapshot of United States Sarcoidosis Patients and their Perceived Disease Impact: Results of the Sarcoidosis Research Institute SurveyOgugua Ndili Obi, Paula Yette Polite, Kenneth M Fish, et al.Lung|June 27, 2023
The Relationship Between Serum Angiotensin Converting Enzyme Level and the Decision to Escalate Treatment of SarcoidosisBoris Shkolnik, Rou Sore, Muhammad Salick, et al.American Journal of Physiology. Heart and Circulatory Physiology|December 24, 2024
A minimally invasive swine model of chronic kidney disease-associated heart failureSpyros A Mavropoulos, Tadao Aikawa, Renata Mazurek, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
SERCA2a gene transfer enhances eNOS expression and activity in endothelial cellsLahouaria Hadri, Regis Bobe, Yoshiaki Kawase, et al.Circulation. Cardiovascular Imaging|April 12, 2023
Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial InfarctionCarlos G Santos-Gallego, Juan Antonio Requena-Ibáñez, Belen Picatoste, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2012
Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine heartsIoannis Karakikes, Lahouaria Hadri, Kleopatra Rapti, et al.Molecular Imaging|May 22, 2010
Molecular imaging agents specific for the annulus fibrosus of the intervertebral diskSummer L Gibbs-Strauss, Carrie Vooght, Kenneth M Fish, et al.Plos One|May 24, 2013
Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosisDennis Ladage, Elisa Yaniz-Galende, Kleopatra Rapti, et al.Journal of the American College of Cardiology|April 20, 2019
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial EnergeticsCarlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.Pageof 13